Medicare Weight Loss Coverage: What You Need to Know

Interest in weight loss medications has grown rapidly in recent years, driven in part by the rising visibility of GLP-1 drugs and their use in treating obesity and related health conditions. Maintaining a healthy weight can have many health benefits, including helping reduce the risk of developing conditions such as type 2 diabetes, heart disease, and sleep apnea.  

As awareness grows, questions about Medicare coverage have become more common. This guide explains how each part of Medicare applies to weight management services, what’s required to qualify, typical costs, and how evolving policy affects newer medications. The aim is to make Medicare weight loss coverage understandable and practical, so you can plan care that fits your health needs and budget.

Medicare coverage of weight loss treatments 

Medicare covers services that are medically necessary to diagnose, treat, or manage disease. Coverage for those services is divided across the different parts of Medicare.   

Part A generally covers inpatient hospital care, while Part B covers outpatient services like doctor visits and certain preventive care. Part C combines the services of Part A and B into a single plan and Part D provides prescription drug coverage. How weight loss services are covered depends on which part applies and the specific service you receive. 

Review the table below to see how the different parts of Medicare cover treatments related to weight loss:

Medicare coverage can vary significantly depending on the type of treatment involved. Medicare coverage rules differ for surgical interventions, counseling services, prescription drugs like GLP-1 medications, and hospital care tied to obesity-related conditions. 

Does Medicare cover bariatric surgery? 

Medicare may cover bariatric (weight loss) surgery for those experiencing morbid obesity.¹ Coverage is restricted to specific surgical procedures that the Centers for Medicare & Medicaid Services (CMS) has determined to be reasonable and necessary and are performed at designated facilities. 

To qualify for Medicare coverage of bariatric surgery, the following criteria generally must be met:² 

• A body mass index (BMI) of 35 or higher 

• At least one obesity-related health condition, such as type 2 diabetes, heart disease, or other serious comorbid conditions that may improve with weight loss 

• Documented evidence of previous unsuccessful attempts to treat obesity 

Original Medicare typically covers the following types of bariatric surgery: 

• Roux‑en‑Y gastric bypass (RYGBP) – a procedure that reduces stomach size and reroutes digestion to limit food intake and nutrient absorption 

• Laparoscopic adjustable gastric banding (LAGB) – involves placing an adjustable band around the upper stomach to restrict how much food can be consumed 

• Biliopancreatic diversion with duodenal switch (BPD/DS) – a more complex surgery that combines stomach reduction with significant intestinal bypass to reduce absorption 

Weight loss therapy (obesity behavioral therapy) 

Medicare may cover weight loss counseling and behavioral therapy for those who have a BMI of 30 or more.³ These services focus on helping individuals make long-term lifestyle changes, including improvements to diet, physical activity, and overall health behaviors, rather than short-term or cosmetic weight loss. 

Unlike surgical or drug-based treatments, this type of therapy is designed to support sustainable weight management through structured guidance and ongoing support from a healthcare provider. 

Medicare-covered weight loss counseling may include:⁴ 

• Obesity screening, including measurement of BMI to determine eligibility 

• Dietary and nutritional assessment to identify areas for improvement in eating habits 

• Regular follow‑up visits to track progress and reinforce weight management strategies over time 

GLP-1 medications and Medicare 

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of prescription medications that mimic a natural hormone your body releases after eating.⁵ They work by slowing digestion, reducing appetite, and helping regulate blood sugar levels. Originally developed to treat type 2 diabetes, GLP-1 drugs have gained significant attention for their effectiveness in treating obesity and supporting sustained weight loss. 

Medicare doesn’t currently cover medications used only for weight loss, but new programs are being explored that may expand access to certain GLP‑1 drugs in the future.  

Medicare Part D, created in 2003, prohibited Medicare from covering medications prescribed solely for weight loss.⁵ This means that even though GLP-1 drugs are proving effective for weight management, Medicare does not cover them when they are prescribed specifically for weight loss. 

Medicare Part D may cover certain GLP-1 drugs when they are prescribed to treat other FDA-approved conditions rather than weight loss alone. The following common GLP-1 drugs aid in the management of certain health conditions as well as weight loss:⁶ 

• Ozempic^®, Rybelsus^®, Mounjaro^® – these may be prescribed for blood sugar control in patients with type 2 diabetes 

• Wegovy^® – this drug may help reduce the risk of cardiovascular death, heart attack, or stroke in adults with cardiovascular disease who are overweight or obese 

• Zepbound^® – this may be used to help treat moderate to severe obstructive sleep apnea in adults with obesity 

Coverage in these cases still depends on the specific Part D plan's formulary, prior authorization requirements, and other utilization management rules.

When will Medicare cover weight loss drugs? 

Many people enrolled in Medicare have questions about whether broader coverage for GLP-1 medications could become available in the future. While Medicare has historically prohibited coverage of drugs used solely for weight loss, two recent CMS initiatives—titled the GLP‑1 Bridge and the BALANCE Model—are designed to test limited access to these medications and assess whether expanded coverage could be feasible over time. 

The Medicare GLP‑1 Bridge 

The Medicare GLP-1 Bridge is a temporary program designed to provide limited access to certain GLP-1 medications used for weight loss.⁷ Beginning in July 2026, people enrolled in Medicare who meet eligibility requirements may be able to receive select GLP-1 drugs at a reduced cost  for the duration of this test program. 

Rather than changing Medicare Part D coverage rules, the Bridge operates outside the standard Part D benefit. CMS administers the program directly, allowing access to specific medications while collecting data on utilization, costs, and potential health outcomes. Participation is time‑limited, and eligibility requirements apply. 

The GLP-1 Bridge is intended as a short-term solution and does not guarantee permanent Medicare coverage of weight loss drugs. Instead, it serves as a transitional step while CMS institutes the BALANCE model. 

The BALANCE Model 

The BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) represents a broader, longer-term approach CMS is exploring to potentially expand Medicare coverage for weight loss medications, including the GLP-1 drugs Mounjaro, Ozempic, Rybelsus, and Wegovy, the KwikPen formulation of Zepbound, and Foundayo™ - one of the newest FDA-approved GLP-1 medications for weight loss.⁸ The model is designed to test whether increased access, combined with lifestyle and nutritional support, could improve health outcomes for people with obesity and reduce long-term healthcare costs. 

Questions to ask your doctor about weight loss coverage 

Talking with your doctor is an important step in understanding your weight loss options under Medicare. Coming prepared with the right questions can help you make informed decisions about your care and coverage. 

1. Am I eligible for Medicare-covered weight loss services? Ask your doctor whether you meet the criteria for coverage, such as having a BMI of 30 or higher or a weight-related health condition like type 2 diabetes or heart disease. 

2. Which weight loss treatments do you recommend for my situation? Your doctor can help determine whether behavioral counseling, bariatric surgery, GLP-1 medications, or a combination of approaches is most appropriate based on your health history and goals. 

3. What documentation is needed for Medicare approval? Certain treatments, such as bariatric surgery, require prior authorization and supporting medical records. Ask what steps are involved and how your doctor's office can assist with the process. 

4. Are there any out-of-pocket costs I should expect? Even with Medicare coverage, some services may involve copays, coinsurance, or deductibles. Understanding your potential costs upfront can help you plan accordingly. 

5. Does this treatment require a referral or prior authorization? Some weight loss procedures and programs require advance approval from Medicare or your Medicare Advantage plan before they are covered. 

6. How will my progress be monitored over time? Ask about follow-up appointments, benchmarks for success, and how your treatment plan may be adjusted based on your results. 

While Medicare coverage for weight loss medications remains limited, more established coverage options are available for several related conditions. For example, Medicare may cover CPAP therapy and supplies for diagnosed sleep apnea, as well as glucose monitors, insulin, and other diabetic supplies when eligibility criteria are met. Exploring coverage for these related services can help clarify available options while broader policies around weight loss medications continue to evolve. 

Frequently asked questions 

Q1. Does Medicare cover weight loss drugs?

Generally, Part D does not cover medications used solely for weight loss. When a drug is FDA-approved for another condition, such as type 2 diabetes or certain cardiovascular risk reductions, and prescribed for that approved use, your Part D or Medicare Advantage plan may cover it, subject to formulary rules and prior authorization.  

Q2. What weight loss services may have no cost sharing?

If eligible, Part B covers intensive behavioral therapy for obesity with no cost sharing when delivered by a primary care provider in a primary care setting and the provider accepts assignment. Preventive obesity screening is also covered. 

Q3. Can bariatric surgery be covered for a BMI below 35?

To cover bariatric surgery, Medicare generally requires a BMI of 35 or greater along with at least one other obesity-related medical condition, plus previous unsuccessful medical treatment of obesity. Exceptions are uncommon and depend on medical necessity and clinical documentation.  

Q4. How do I appeal a coverage denial?

You have the right to appeal. Review your Medicare Summary Notice or plan Explanation of Benefits for denial reasons and deadlines. Work with your provider to submit medical records and letters of medical necessity. For Part D drugs, your prescriber can request a formulary exception or prior authorization with detailed rationale. State Health Insurance Assistance Program (SHIP) counselors offer free help. 

Q5. What out-of-pocket costs should I expect for weight loss coverage with Medicare?

Under Original Medicare, you’re typically responsible for the Part B deductible and 20% coinsurance for outpatient services unless preventive criteria are met. Part A deductibles and coinsurance apply to inpatient stays. If you have a Medicare supplement policy, it may help cover certain out-of-pocket costs that remain after Original Medicare pays its share. Medicare Advantage costs depend on plan copays, coinsurance, and whether care is received from in-network providers.

Sources

¹ Medicare.gov. Bariatric surgery. Retrieved April 30, 2026, from www.medicare.gov/coverage/bariatric-surgery  

² Centers for Medicare & Medicaid Services (CMS). Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity. Retrieved April 30, 2026, from www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=57&ncdver=5&= 

³ Medicare.gov. Obesity Behavioral Therapy. Retrieved April 30, 2026, from www.medicare.gov/coverage/obesity-behavioral-therapy  

⁴ Centers for Medicare & Medicaid Services (CMS). Intensive Behavioral Therapy for Obesity. Retrieved April 30, 2026, from www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=353  

⁵ Congressional Research Service. Coverage and Payment for Anti-Obesity Medications Under Medicare Part D. Retrieved April 30, 2026, from www.congress.gov/crs-product/IF12758 

⁶ GoodRX. Ozempic, Trulicity, and More: 11 GLP-1 Drugs and How to Navigate Your Options. Retrieved April 30, 2026, from www.goodrx.com/classes/glp-1-agonists/glp-1-drugs-comparison  

⁷ Centers for Medicare & Medicaid Services (CMS). Medicare GLP-1 Bridge Guidance. Retrieved April 30, 2026, from www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge 

⁸ Centers for Medicare & Medicaid Services (CMS). BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model. Retrieved April 30, 2026, from www.cms.gov/priorities/innovation/innovation-models/balance  

Item #649182